{"schema_version":"secwatch.filing_event.v1","accession":"0001654954-25-006837","form_type":"8-K","ticker":"ZIVO","cik":"0001101026","company_name":"Zivo Bioscience, Inc.","filed_at":"2025-06-11T23:59:59+00:00","discovered_at":"2026-05-14T18:02:47.521656+00:00","generated_at":"2026-05-19T12:33:08.027950+00:00","sec_items":["5.07"],"event_type":"other","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.15,"confidence":"high","headline":"Zivo Bioscience shareholders elect directors, ratify auditor, and approve executive compensation at annual meeting","bullets":["Elected John B. Payne and Alison A. Cornell as Class III directors with 1,681,190 and 1,681,001 votes for, respectively; broker non-votes 792,911.","Ratified BDO USA, P.C. as independent auditor for fiscal year 2025 with 2,438,089 votes for, 53,549 against, 15,420 abstain.","Advisory approval of named executive officer compensation: 1,665,583 for, 48,443 against, 121 abstain; broker non-votes 792,911.","Total shares present at meeting: 2,507,058 (66.11% of outstanding common stock)."],"urls":{"canonical":"https://secwatch.observer/filing/0001654954-25-006837","json":"https://secwatch.observer/filing/0001654954-25-006837.json","markdown":"https://secwatch.observer/filing/0001654954-25-006837.md","text":"https://secwatch.observer/filing/0001654954-25-006837.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1101026/000165495425006837/0001654954-25-006837-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1101026/000165495425006837/zivo_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud","generated_at":"2026-05-19T12:33:08.027950+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}